J.P. Morgan has officially jumped into early stage biotech investing
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: drug pricing
STAT+: Does Sanders have the votes to subpoena a Novo exec?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
With Avidity and Pfizer, gene therapy enters a phase
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What do Parkinson’s and obesity have in common?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: The J&J lawsuit should be a wakeup call to the PBM industry — and to companies everywhere
The ongoing legal dispute involving Johnson & Johnson has again thrust the topic of pharmacy…
Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Vanda Pharmaceuticals has another suitor
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novovax will be able to supply Covid-19 vaccines this fall
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Testing begins for a new form of PrEP
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Operation Warp Speed but for rare disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Can AstraZeneca make good on its promise?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
The surprising outperformance of a new drug against existing competitors, and other biotech updates
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Wegovy linked to lower risk of alcohol use disorder in real-world study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biotech’s most interesting fundraisings from the last week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
More tumult at BIO amid the company’s fourth CEO in four years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Maryland takes first steps to cap drug costs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Lilly doubles down on radiopharma
Want to stay on top of the science and politics driving biotech today? Sign up to get…
AstraZeneca antibody reduced Covid-19 risk in immunocompromised
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Blackstone wants in on red-hot immunology market
The need-to-know this morning Biogen and Ionis Pharmaceuticals are ending their development of an experimental drug for ALS based on…
Leqembi gets closer to being offered as an injection
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Cutting-edge insulin is good. But it’s the ‘trailing edge’ of older versions that can keep it affordable
Physicians Frederick Banting and John MacLeod declined to be listed on the patent for insulin…
Is Novavax a new meme stock?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
We now know Tome’s gene editing target
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The public wants Medicare to cover obesity drugs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Yet another big financing round in immunology
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Pharma has over $500B in capital for deals
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Vertex starts gene therapy Casgevy in five patients
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: The world is relying on the United States to get value-based drug pricing right
The changing landscape of drug pricing policy in the U.S. has implications for the global…
Merck may have a competition for ever-scarce BCG
Want to stay on top of the science and politics driving biotech today? Sign up to get…
ICER casts doubt on Sarepta’s DMD gene therapy
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Senate drug shortage bill would pay hospitals bonuses for good contracting practices
WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages…
The biotech news you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The latest government crackdowns on biotech you need to know
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: FTC issues more warnings to drug companies for ‘junk’ patent listings
The U.S. Federal Trade Commission expanded its campaign against pharmaceutical companies for filing what it…
FDA wants to hear your thoughts on advisory committees
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Federal judge rules against two drugmakers challenging Medicare drug price negotiation program
WASHINGTON — A federal judge in New Jersey on Monday dealt a blow to two…
STAT+: Vertex offers limited access to a cystic fibrosis drug in South Africa — and may undercut a court case
After months of sustained criticism, Vertex Pharmaceuticals reached an agreement to provide a pricey cystic…
STAT+: Thanks to CVS, a biosimilar version of AbbVie’s Humira is grabbing huge market share
The number of new prescriptions written for biosimilar versions of the Humira rheumatoid arthritis treatment,…
What about the company Vertex didn’t buy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more
And so, another working week will soon draw to a close. Not a moment too…
Gas prices are hurting biotech
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Regeneron accused by Justice Department of manipulating Medicare pricing
The U.S. Department of Justice filed a lawsuit accusing Regeneron Pharmaceuticals of manipulating Medicare pricing…
AskBio CSO steps down, has new project in stealth mode
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Pfizer’s plot to win the RSV vaccine race
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Sanofi resolves most Zantac litigation
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market
WASHINGTON — Boehringer Ingelheim is laying off or relocating its sales staff for its Humira biosimilar…
How resurrecting extinct species might impact medicine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
New data on liquid biopsy for colorectal cancer detection still underwhelms
Want to stay on top of the science and politics driving biotech today? Sign up to get…